How can Science 37 improve its mobile app interface to streamline patient data collection during clinical trials?

Introduction

To improve Science 37's mobile app interface for streamlining patient data collection during clinical trials, we need to focus on enhancing user experience, data accuracy, and compliance with regulatory requirements. I'll analyze the current state, identify pain points, and propose solutions that address the unique challenges of remote clinical trials.

Clarifying Questions (5 mins)

• Looking at the product context, I'm thinking Science 37 might be targeting a diverse patient population. Could you help me understand the primary user demographics and their tech-savviness levels?

Why it matters: Determines the complexity and accessibility requirements of our interface design. Expected answer: Diverse age groups with varying tech literacy levels. Impact on approach: Would focus on intuitive design and potentially multi-modal data input options.

• Considering the critical nature of clinical trials, I'm curious about the current data collection accuracy rates. What's our baseline for data quality, and are there specific areas where errors frequently occur?

Why it matters: Identifies priority areas for improvement and potential compliance risks. Expected answer: 90% accuracy overall, with challenges in time-sensitive inputs and complex medical terminology. Impact on approach: Would prioritize features that enhance data validation and user guidance.

• Given the evolving landscape of decentralized clinical trials, I'm wondering about our competitive position. How does our mobile app compare to other solutions in the market in terms of user satisfaction and trial completion rates?

Why it matters: Helps identify unique selling points and areas for differentiation. Expected answer: Above average in user satisfaction, but trailing in trial completion rates. Impact on approach: Would focus on features that improve long-term engagement and reduce dropout rates.

• Thinking about the product lifecycle, I'm curious about the app's current adoption rate and user retention. What percentage of eligible patients are actively using the app throughout their trial participation?

Why it matters: Indicates whether we should focus on onboarding, engagement, or both. Expected answer: 80% initial adoption, but only 60% consistent usage throughout trials. Impact on approach: Would emphasize features that encourage regular engagement and simplify ongoing participation.